Blogs
Body Revival Clinical Trial Explained: What CTRI/2023/11/059465 Actually Shows
Medically reviewed by: Dr. Farah Zariwala (BHMS)
Last updated: 04/08/2026
Most Ayurvedic wellness products rely on tradition and testimonials alone. Body Revival took a different route: a registered, hospital-based clinical trial. This page breaks down exactly what that trial involved, what it measured, and — just as importantly — what it doesn't claim, so you can evaluate the evidence for yourself rather than take a marketing headline at face value.
The Trial, in Plain Terms
- Registry: Clinical Trials Registry of India (CTRI), under ICMR
- Registration number: CTRI/2023/11/059465
- Phase: Phase II
- Site: J.B. Roy State Ayurvedic Medical College & Hospital, Kolkata — one of India's oldest state Ayurvedic institutions
- Population studied: Post-surgery breast cancer patients undergoing chemotherapy and/or radiotherapy
- Design: Randomized, controlled study
- Duration: Approximately 11 months of trial conduct (October 2023 – November 2024), with patients followed for a defined treatment window
Why registration matters
Anyone can claim a product was "clinically tested." A CTRI registration means the trial's design, population, and intended outcomes were filed with a public registry before results were published — which is what allows independent verification. You can look up the registration yourself rather than relying on any company's summary of it, including this one.
What the Trial Measured
The trial focused on supportive-care outcomes during active cancer treatment, not on treating or curing cancer itself. Reported areas of measurement included:
- Quality of life (QoL): physical vitality, appetite, mental clarity, and emotional well-being during chemotherapy/radiotherapy
- Performance status: patients' day-to-day functional capacity during treatment
- Treatment-related side effects: frequency/severity of symptoms such as nausea, fatigue, dizziness, and muscle weakness commonly associated with chemotherapy and radiation
Company-reported summaries of the trial describe improvements across these measures for patients using Body Revival alongside standard treatment, compared to patients on standard treatment alone. As with any single trial, these are the sponsor's own reported outcomes; independent replication and peer-reviewed publication are what would move this from "one completed trial" to broadly accepted clinical evidence — and that distinction matters if you're deciding whether it's relevant to your own situation.
What This Trial Does NOT Show
To be direct about the limits of this evidence:
- It does not show that Body Revival treats, cures, prevents, or slows the progression of cancer.
- It was not designed to replace chemotherapy, radiotherapy, surgery, or any oncologist-prescribed treatment.
- It studied one cancer type (breast cancer, post-surgery) — results shouldn't be assumed to generalize to other cancers without further study.
- It's one completed trial at one institution. That's a meaningful step for an Ayurvedic supportive-care product, but it's not the same evidence base as a treatment drug that's gone through multi-site Phase III trials.
Body Revival is registered as a supportive-care Ayurvedic product under AYUSH and is not intended to treat, cure, or manage cancer or any disease. It should only be used as a complementary measure alongside treatment prescribed by a qualified oncologist, and any use during active cancer treatment should be discussed with your treating doctor first — particularly around any possible interaction with chemotherapy or radiation.
How to Verify This Yourself
- Search the registration number CTRI/2023/11/059465 directly on the CTRI public registry
- Check the listed trial site, J.B. Roy State Ayurvedic Medical College & Hospital, Kolkata, independently
- Ask your own oncologist whether they're aware of the trial and what weight they'd give it for your specific case
Where This Fits in Your Care
If you or a family member is going through breast cancer treatment and considering Ayurvedic supportive care, this trial is a reasonable starting point for a conversation with your oncologist — not a substitute for one. See how Body Revival is used alongside prescribed treatment →
Frequently Asked Questions
Body Revival is registered under India's AYUSH system as an Ayurvedic supportive-care product, not as a drug. It is not positioned as, and should not be understood as, an FDA-approved cancer treatment.
No. Body Revival is designed to be used alongside doctor-prescribed cancer treatment, not as a replacement for it. Stopping or delaying prescribed treatment in favor of a supportive-care product is not supported by this trial or by Body Revival's own labeling.
The trial is publicly searchable on the Clinical Trials Registry of India using registration number CTRI/2023/11/059465.